After two consecutive weeks as the strongest sector in the S&P 500, tech’s reign came to an end. And not only did technology stocks not… Read More »Tech’s Winning Streak Ends … What’s Next?

November is a special time of year. In fact, it’s not just the 11th month that’s special… November kicks off a supercycle for stocks lasting… Read More »This Stock Is An All-Star For The November Buy Window

Investors who watched the robotics space peak back in 2021 may see the current rally with apprehension. Back then, the narrative of a China-driven logistics… Read More »3 Reasons This New Robotics Super Cycle Is Different

It was late 2024. President Yoon Suk Yeol had just thrown South Korea into crisis. And while the emergency only lasted about six hours… it… Read More »This Is One Of The Market’s Best-Kept Secrets

Pharma’s strong pipelines, reduced policy risks, and demand growth drive renewed investor interest. This Pharmaceutical ETF offers targeted access to top innovators like Eli Lilly… Read More »Top Pharmaceutical Companies Shaping The Future Of Healthcare

As widely expected, the U.S. Federal Reserve cut the federal funds rate by 25 basis points for a second time this year. This gives fixed… Read More »Fixed Income Options After Second Fed Rate Cut

ASML Holding N.V. (ASML) is the world’s sole manufacturer of extreme ultraviolet (EUV) lithography systems, indispensable for fabricating sub-4nm semiconductors that power AI, data centers,… Read More »This ‘Strong Buy’ Stock Is The Linchpin In Next-Gen Semi Stocks

A recent Wall Street Journal article, “The Frothiest AI Bubble Is in Energy Stocks,” highlighted the fact that investors are looking for any way to… Read More »Is The AI Build-Out Causing An Energy Bubble?

The current bull market is now entering its fourth year, and it shows no signs of slowing down. Despite macroeconomic concerns and growing warnings of… Read More »3 Opportunities In Today’s Bull Market

It’s rare to find a small biotech stock that’s likely standing on the edge of a medical breakthrough – but Stoke Therapeutics (Nasdaq: STOK) is… Read More »This Biotech Is On The Verge Of A Breakthrough